Prix
Questions fréquentes
Quelle est la capitalisation boursière de PacBio ?
Quel est le bénéfice par action (BPA) de PacBio ?
Quelles sont les évaluations des analystes et le prix cible de l'action PacBio ?
Quel est le chiffre d'affaires de PacBio sur les douze derniers mois ?
Quel est l'EBITDA de PacBio ?
Quel est le flux de trésorerie disponible de PacBio ?
Quel est le bêta à 5 ans de l'action PacBio ?
Combien d'employés compte PacBio, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de PacBio ?
Finances
Capitalisation boursière
484,74 M $USbêta sur 5 ans
1,96BPA (TTM)
-1,456 $USFree Float
268,75 MRecettes (TTM)
173,15 M $USEBITDA (TTM)
-269,82 M $USCash-flow disponible (TTM)
-239,56 M $USCotation
Notes des analystes
L'objectif de prix est de 3,292 $US et l'action est analysée par 15 analystes.
Acheter
7
Hold
8
Vendre
0
Informations
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
796
Medical Equipment & Supplies
Soins de santé
Identifiant
ISIN
Ticker primaire